M
Miia Kivipelto
Researcher at Karolinska University Hospital
Publications - 516
Citations - 70761
Miia Kivipelto is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Dementia & Population. The author has an hindex of 91, co-authored 447 publications receiving 58328 citations. Previous affiliations of Miia Kivipelto include National Institute for Health and Welfare & National Institutes of Health.
Papers
More filters
Book ChapterDOI
Sex and gender differences in genetic and lifestyle risk and protective factors for dementia
Shireen Sindi,Shireen Sindi,Sima Toopchiani,Mariagnese Barbera,Krister Håkansson,Jenni Lehtisalo,Jenni Lehtisalo,Anna Rosenberg,Ruth Stephen,Chinedu T. Udeh-Momoh,Miia Kivipelto +10 more
TL;DR: The goal of this chapter is to summarize the current evidence on sex differences in genetic and modifiable lifestyle factors that are associated with dementia risk, and sex-specific factors such as menopause and andropause, and potential mechanisms such as neural reserve and resilience.
Journal ArticleDOI
Results and experiences from Scandinavian multi-domain intervention trials (DRs EXTRA and FINGER)
Alina Solomon,Tiia Ngandu,Satu Ahtiluoto,Antti Jula,Tiina Laatikainen,Rainer Rauramaa,Timo E. Strandberg,Jaakko Tuomilehto,Hilkka Soininen,Miia Kivipelto +9 more
Journal ArticleDOI
Dementia Prevention: A Global Challenge in Urgent Need of Solutions
TL;DR: This issue addresses a range of aetiological risk factors for LOD, novel technologies and study designs, with implications for preventative strategies, and presents an example of developments in the genetic prediction of the risk and clinical manifestation of dementia.
Journal ArticleDOI
Statins and dementia prevention: A population-based study (FINRISK)
Journal ArticleDOI
O1-02-06
Rachel A. Whitmer,Deborah E. Barnes,Miia Kivipelto,Charles P. Quesenberry,Tiia Ngandu,Kristine Yaffe +5 more
TL;DR: It is suggested that anti-A vaccine might be effective as prophylactic, but not therapeutic measure and should be used for vaccination of middle-aged healthy people.